Price Forecast:

Bullish Case: Positive efficacy data from RMC-6236 trials could drive RVMD's price higher, exceeding $65, led by robust investor sentiment and strategic advancements in treatment paradigms.

Bearish Case: Negative trial outcomes or regulatory delays could decrease RVMD to below $50, exacerbated by high operational costs and investor skepticism reflected in the market.

Potential Outcomes:

1. Positive trial results (70%): RVMD price increases 20-35%.

2. Mixed results (15%): Price volatility near current levels.

3. Failure results (15%): Price drop of 25% or more, falling below $45.

Trading Oracle: Consider a bullish strategy using debit spreads, buying $60 call and selling $65 call, targeting expiration before trial results. Implied volatility remains high; 1.9 to 1 reward-risk ratio expected. Adjust as market conditions evolve. Avalanche potential exists for positive surprise in data releases, making it very actionable now.

November 13, 2024